发明名称 Compositions and methods including recombinant B lymphocyte cell line including an exogenously incorporated nucleic acid expressing an exogenous membrane immunoglobulin reactive to a first antigen and including an endogenous gene expressing an endogenous secreted immunoglobulin reactive to a second antigen
摘要 Compositions and methods are disclosed herein for producing one or more immunoglobulins in an isolated B lymphocyte cell line. An isolated cell line includes an isolated B lymphocyte cell line capable of expressing at least one exogenously incorporated membrane immunoglobulin reactive to a first antigen and at least one endogenous secreted immunoglobulin reactive to a second antigen.
申请公布号 US9512213(B2) 申请公布日期 2016.12.06
申请号 US201414549685 申请日期 2014.11.21
申请人 Elwha LLC 发明人 Hyde Roderick A.;Kindsvogel Wayne R.
分类号 A61K35/12;A01N63/00;C07K16/18;A61K39/00;C12N5/0781;C07K16/00;C07K16/10;C07K16/12;C07K16/30;C07K16/44;G01N33/68 主分类号 A61K35/12
代理机构 代理人
主权项 1. A method for treating a disease in a vertebrate subject with an immunotherapeutic product comprising: isolating from a vertebrate subject exposed to at least one second antigen, a B lymphocyte cell expressing at least one endogenous secreted immunoglobulin reactive to the at least one second antigen; introducing into the isolated B lymphocyte cell at least one exogenous membrane immunoglobulin reactive to at least one first antigen to produce a recombinant B lymphocyte cell; selecting the recombinant B lymphocyte cell expressing the membrane immunoglobulin reactive to the at least one first antigen and expressing the at least one endogenous secreted immunoglobulin reactive to the at least one second antigen; and administering a therapeutically effective amount of said recombinant B lymphocyte cell to one or more vertebrate subjects afflicted with disease.
地址 Bellevue WA US